DexCom's Quiet Consolidation After Huge Decline

By: via Benzinga
DexCom, Inc. (NASDAQ: DXCM) shares got hammered Sept. 28 when rival Abbott Laboratories (NYSE: ABT) receivedFDA approval for its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.